槲皮素口服补充对PRRSV-1改良活病毒疫苗免疫猪抵抗HP-PRRSV-2攻击的效应
本研究评价槲皮素对猪繁殖与呼吸综合征病毒1型(PRRSV-1)改良活病毒(MLV)疫苗交叉保护高致病性PRRSV-2(HP-PRRSV-2)攻击的免疫调节作用。体外实验显示槲皮素显著增强I型干扰素调节基因及I、II型干扰素表达,并显著降低HP-PRRSV接种的单核细胞衍生巨噬细胞的促炎与抗炎细胞因子表达。体内实验将24头4周龄猪分为四组,每组6头,结果显示槲皮素组较疫苗单用组显著降低HP-PRRSV病毒血症,但未进一步改善PRRSV特异性抗体反应、直肠温度、临床评分和平均日增重。
要点
- 槲皮素组较疫苗单用组显著降低HP-PRRSV病毒血症,但未进一步改善抗体反应、直肠温度、临床评分和平均日增重。
- 槲皮素组较疫苗单用组显著增加IFN调节因子3、干扰素基因刺激因子和IFNα mRNA表达,并显著降低TGFβ mRNA表达。
- 作者认为槲皮素可能作为口服免疫调节剂增强对HP-PRRSV的细胞免疫防御。
核心结论
- 研究提示槲皮素上调干扰素调节基因、IFNα并下调TGFβ mRNA表达,可能有助于进一步减少病毒血症猪数量及PRRSV-1 MLV疫苗所赋予的HP-PRRSV病毒血症。
- 研究还提示槲皮素可能作为有效的口服免疫调节剂改善对HP-PRRSV的细胞免疫防御。
研究设计与样本
- 体外实验:槲皮素处理HP-PRRSV接种的单核细胞衍生巨噬细胞,检测I型干扰素调节基因、I和II型干扰素及促炎与抗炎细胞因子表达。
- 体内实验:4周龄猪(n=24)分为四组、每组6头;第1组和第2组于0 dpv免疫PRRSV-1 MLV疫苗,第2组另于0-49 dpv口服槲皮素,第3组于0 dpv注射PRRSV-1 MLV疫苗溶剂,第4组为严格对照。
- 第1-3组于28 dpv经鼻接种HP-PRRSV,每周监测免疫和临床指标至49 dpv。
主要发现
- 体外实验:槲皮素显著增强HP-PRRSV接种的单核细胞衍生巨噬细胞的I型干扰素调节基因及I、II型干扰素表达,并显著降低促炎与抗炎细胞因子表达。
- 与第3组相比,第1组显著降低HP-PRRSV病毒血症、直肠温度和临床评分,并显著改善平均日增重(ADWG)。
- 与第1组相比,第2组显著增加IFN调节因子3、干扰素基因刺激因子和IFNα mRNA表达,并显著降低TGFβ mRNA表达。
- 与第1组相比,第2组显著降低HP-PRRSV病毒血症,但未进一步改善PRRSV特异性抗体反应、直肠温度、临床评分和ADWG。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study evaluated the immunomodulatory effect of quercetin on improving cross protection of porcine reproductive and respiratory syndrome virus-1 (PRRSV-1) modified-live virus (MLV) vaccine against highly pathogenic (HP)-PRRSV-2 challenge. Ex vivo experiments demonstrated that quercetin significantly enhanced type I interferon-regulated genes (IRGs) and type I and II interferon (IFN), and significantly decreased pro- and anti-inflammatory cytokine expressions in HP-PRRSV-inoculated monocyte-derived macrophages. In vivo experiments divided pigs (4-week-old; n = 24) into four groups of six pigs. Group 1 and group 2 were immunized with PRRSV-1 MLV vaccine at 0 dpv (day post vaccination). Group 2 also received oral administration of quercetin at 0-49 dpv. Group 3 was injected with PRRSV-1 MLV vaccine solvent at 0 dpv. Group 4 served as strict control. Group 1-3 were challenged intranasally with HP-PRRSV at 28 dpv and immune and clinical parameters were monitored weekly until 49 dpv. Group 1 demonstrated significantly reduced HP-PRRSV viremia, rectal temperature and clinical scores, and significantly improved average daily weight gain (ADWG), compared to group 3. Group 2 demonstrated significantly increased IFN regulatory factor 3, stimulator of IFN genes, IFNα, and significantly decreased transforming growth factor beta (TGFβ) mRNA expressions, compared to group 1. The animals demonstrated significantly reduced HP-PRRSV viremia, but did not demonstrate any further improved PRRSV-specific antibody responses, rectal temperature, clinical scores, and ADWG as compared to group 1. Our findings suggest that quercetin up-regulates IRGs, IFNα, and down-regulates TGFβ mRNA expressions which may contribute to further reducing number of viremic pigs and HP-PRRSV viremia which were conferred by PRRSV-1 MLV vaccine. Our findings also suggest that quercetin may serve as an effective oral immunomodulator for improving cell-mediated immune defense to HP-PRRSV.
引用
- Ruansit W, Charerntantanakul W. Oral supplementation of quercetin in PRRSV-1 modified-live virus vaccinated pigs in response to HP-PRRSV-2 challenge. Vaccine. 2020. PMID: 32184034. doi:10.1016/j.vaccine.2020.03.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。